![]()
| ||||||||||||||||||
|
109
1 The State of Ohio, )
2 County of Lorain ) SS:
3
4 IN THE COURT OF COMMON PLEAS
5 THE STATE OF OHIO, )
Plaintiff; )
6 vs ) No 04CR065940
RUBEN O RIVERA, )
7 Defendant )
8 THE STATE OF OHIO, )
Plaintiff; )
9 vs ) No 05CR068067
)
10 RONALD McCLOUD, )
Defendant )
11
***
12
COMPLETE TRANSCRIPT OF PROCEEDINGS
13
MONDAY, APRIL 7, 2008 - VOLUME II
14
***
15
BE IT REMEMBERED, that on Monday, the 7th day of
16
April, 2008, being one of the regular days of the April
17
term of said court, before the Honorable James M Burge,
18
the Presiding Judge of said court, the above-captioned
19
causes came on for hearing upon Defendants' Motion to
20
Declare the Lethal Injection Protocol Unconstitutional
21
***
22
23
24
25
110
1 AFTERNOON SESSION, MONDAY, APRIL 7, 2008
2 THE COURT: All right We left off in this
3 morning's proceedings with -- still in Dr Heath's direct
4 testimony
5 I think that we were able to narrow the factual
6 issues, at least from Dr Heath's testimony His
7 testimony, if I understand it correctly, would be that the
8 administration of potassium chloride without anesthetic
9 would be very painful; that the administration of
10 pancuronium bromide, while not necessarily painful, would
11 at least be anguish-filled, since the condemned couldn't
12 breathe; and that the crux of the issue lies with the
13 administration of thiopental, which is the anesthetic
14 drug
15 I think that the doctor has made it clear that if
16 a sufficient amount of thiopental is administered
17 appropriately, it will cause the death of the accused
18 painlessly
19 My understanding of the doctor's reservations
20 about Ohio's protocol can be summed up in the nature of
21 the practice, that is, there isn't a bedside practitioner
22 to determine whether the injection ports have been
23 properly placed to exclude leakage; the length of the
24 intravenous tubes used -- my impression from the testimony
25 was that the longer the tube, the greater the likelihood
111
1 there is of a problem in administering the thiopental --
2 and, as well, with the mixing of the drugs, and the
3 medical acumen required to determine whether they're still
4 active or not active; in sum and substance, the difficulty
5 being with quality assurance with regard to the
6 administration of the thiopental, whether some of it has
7 leaked out, whether the drugs are still efficacious,
8 whether the injection port is clean and on target So I
9 think we're talking about a narrow issue here
10 Can you think of things, Doctor, that I have left
11 out of my summary that are important?
12 THE WITNESS: I think that's a very good summary
13 of the four phases of the procedure Three of them are
14 the administration of each of the drugs, but there are
15 also significant issues with respect to establishing IV
16 access, in that we know, both in the clinical setting and
17 in execution settings, that execution personnel have
18 elected to or been forced to put in a central line, or a
19 cut-down, or some alternative means of access And that's
20 a very specialized procedure, which carries very
21 significant risks of causing injury, and also pain and
22 death
23 And there are a lot of -- so there are a number
24 of issues that attach to that practice And to -- it
25 being very unclear what Ohio's so-called backup plan would
112
1 be if -- or, inevitably, when it encounters that
2 situation, as other states have, and will continue to,
3 just like in clinical practice, it's inevitable that you
4 can't sometimes get a peripheral IV in, and then they have
5 to resort to something else, or cancel the execution, I
6 suppose, or use a different method, I suppose But unless
7 they have a backup plan, that's a standard in lethal
8 injection, and it's an articulated backup plan, and the
9 specifics of the experience and proficiency and
10 credentials of the
| |||||||||||||||||
|
Copyright 2004 - 2010 CrossExam LLC All rights reserved.dmca | ||||||||||||||||||
|
| ||||||||||||||||||